| Literature DB >> 35148317 |
Mosharop Hossian1,2, Md Abdullah Saeed Khan1,3, Anum Nazir4, Mohammad Hayatun Nabi1, Mehedi Hasan1, Ramisha Maliha1, Mohammad Ali Hossain1,5, Md Utba Rashid1,6, Nizwa Itrat4, Mohammad Delwer Hossain Hawlader1.
Abstract
BACKGROUND: Widespread vaccination coverage is essential for reducing the COVID-19 havoc and regarded as a crucial tool in restoring normal life on university campuses. Therefore, our research aimed to understand the intention to be vaccinated for COVID-19 among Pakistani university students.Entities:
Mesh:
Substances:
Year: 2022 PMID: 35148317 PMCID: PMC8836301 DOI: 10.1371/journal.pone.0262305
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Fig 1Administrative unit wise distribution of the study participants (A) and population (B). [Islamabad and Federally Administered Tribal Areas (FATA) were excluded] (Created with ArcGIS version 10.5).
Fig 2Distribution of respondents according to their intention to take vaccine.
Socio-demographic characteristics of the study participants (n = 2865).
| Intention to take COVID-19 vaccine | ||||
|---|---|---|---|---|
| Total | Yes | No | ||
| Variables | n | n (%) | n (%) | |
|
| ||||
| Male | 644 | 461 (71.6) | 183 (28.4) | 0.376 |
| Female | 2201 | 1603 (72.8) | 598 (27.2) | |
| 3rd Gender | 20 | 12 (60.0) | 8 (40.0) | |
|
| ||||
| Married | 86 | 64 (74.4) | 22 (25.6) | 0.066 |
| Unmarried | 2754 | 1999 (72.6) | 755 (27.4) | |
| Divorced/Widowed/ Separated | 25 | 13 (52.0) | 12 (48.0) | |
|
| ||||
| Undergraduate Student | 1866 | 1321 (70.8) | 545 (29.2) | 0.006 |
| Graduate Student | 999 | 755 (75.6) | 244 (24.4) | |
|
| ||||
| No | 2259 | 1625 (71.9) | 634 (28.1) | 0.223 |
| Yes | 606 | 451 (74.4) | 155 (25.6) | |
|
| ||||
| ≤ 20000 | 1953 | 1424 (72.9) | 529 (27.1) | 0.711 |
| 21000 to 40000 | 275 | 198 (72.0) | 77 (28.0) | |
| ≥ 41000 | 637 | 454 (71.3) | 183 (28.7) | |
|
| ||||
| Rural | 414 | 298 (72.0) | 116 (28.0) | 0.888 |
| Semi-urban | 2178 | 1577 (72.4) | 601 (27.6) | |
| Urban | 273 | 201 (73.6) | 72 (26.4) | |
|
| ||||
| Small (⩽ 5) | 1153 | 838 (72.7) | 315 (27.3) | 0.829 |
| Large (≥ 6) | 1712 | 1238 (72.3) | 474 (27.7) | |
Note: p-values were determined by Chi-square tests
† Data expressed as n within rows
‡ Data expressed as n (%) within rows.
Impact and vulnerabilities of COVID-19, past experience of vaccination and their association with the intention to take COVID-19 vaccine.
| Intention to Take COVID-19 Vaccine | ||||
|---|---|---|---|---|
| Total | Yes | No | ||
| Questions on impact and vulnerabilities | n | n (%) | n (%) | |
|
| ||||
| No | 2618 | 1906 (72.8) | 712 (27.2) | 0.181 |
| Yes | 247 | 170 (68.8) | 77 (31.2) | |
|
| ||||
| No | 2292 | 1629 (71.1) | 663 (28.9) | 0.001 |
| Yes | 573 | 447 (78.0) | 126 (22.0) | |
|
| ||||
| No | 1518 | 1058 (69.7) | 460 (30.3) | <0.001 |
| Yes | 1347 | 1018 (75.6) | 329 (24.4) | |
|
| ||||
| No | 2747 | 1983 (72.2) | 764 (27.8) | 0.115 |
| Yes | 118 | 93 (78.8) | 25 (21.2) | |
|
| ||||
| No | 2427 | 1726 (71.1) | 701 (28.9) | <0.001 |
| Yes | 438 | 350 (79.9) | 88 (20.1) | |
Note: p-values were determined by Chi-square tests
† Data expressed as n within rows
‡ Data expressed as n (%) within rows.
Beliefs and attitude towards COVID-19 and its vaccine in relation to intention to take COVID-19 vaccine.
| Intention to Take COVID-19 Vaccine | ||||
|---|---|---|---|---|
| Total | Yes | No | ||
| Questions on belief and attitude | n | n (%) | n (%) | |
|
| ||||
|
| ||||
| No | 740 | 408 (55.1) | 332 (44.9) | <0.001 |
| Yes | 2125 | 1668 (78.5) | 457 (21.5) | |
|
| ||||
| No | 1571 | 1171 (74.5) | 400 (25.5) | 0.006 |
| Yes | 1294 | 905 (69.9) | 389 (30.1) | |
|
| ||||
|
| ||||
| No | 1347 | 924 (68.6) | 423 (31.4) | <0.001 |
| Yes | 1518 | 1152 (75.9) | 366 (24.1) | |
|
| ||||
| No | 1178 | 814 (69.1) | 364 (30.9) | 0.001 |
| Yes | 1687 | 1262 (74.8) | 425 (25.2) | |
|
| ||||
| No | 540 | 299 (55.4) | 241 (44.6) | <0.001 |
| Yes | 2325 | 1777 (76.4) | 548 (23.6) | |
|
| ||||
|
| ||||
| No | 670 | 253 (37.8) | 417 (62.2) | <0.001 |
| Yes | 2195 | 1823 (83.0) | 372 (17.0) | |
|
| ||||
| No | 1043 | 790 (75.7) | 253 (24.6) | 0.003 |
| Yes | 1822 | 1286 (70.6) | 536 (29.4) | |
|
| ||||
| No | 503 | 180 (35.8) | 323 (64.2) | <0.001 |
| Yes | 2362 | 1896 (80.3) | 466 (19.7) | |
|
| ||||
|
| ||||
| No | 741 | 457 (61.7) | 284 (38.3) | <0.001 |
| Yes | 2124 | 1619 (76.2) | 505 (23.8) | |
|
| ||||
|
| ||||
| No | 358 | 180 (50.3) | 178 (49.7) | <0.001 |
| Yes | 2507 | 1896 (75.6) | 611 (24.4) | |
|
| ||||
| No | 1112 | 549 (49.4) | 563 (50.6) | <0.001 |
| Yes | 1753 | 1527 (87.1) | 226 (12.9) | |
Note: p-values were determined by Chi-square tests
† Data expressed as n within rows
‡ Data expressed as n (%) within rows.
Sociodemographic factors, and health-beliefs regarding COVID-19 association with vaccine acceptance.
| Variables | Univariate Analysis | Multivariable Analysis |
|---|---|---|
| OR (95% CI) | AOR (95% CI) | |
|
| ||
| Undergraduate Student | 1 | 1 |
| Graduate Student | 1.28 (1.07–1.52) | 1.30 (1.05–1.61) |
|
| ||
| No | 1 | 1 |
| Yes | 1.44 (1.16–1.79) | 1.15 (0.87–1.50) |
|
| ||
| No | 1 | 1 |
| Yes | 1.35 (1.14–1.59) | 1.15 (0.94–1.42) |
|
| ||
| No | 1 | 1 |
| Yes | 1.62 (1.26–2.07) | 1.22 (0.90–1.65) |
|
| ||
|
| ||
| No | 1 | 1 |
| Yes | 2.97 (2.49–3.55) | 1.59 (1.26–2.01) |
|
| ||
| No | 1 | 1 |
| Yes | 0.79 (0.67–0.94) | 1.00 (0.81–1.22) |
|
| ||
|
| ||
| No | 1 | 1 |
| Yes | 1.44 (1.22–1.70) | 1.10 (0.90–1.36) |
|
| ||
| No | 1 | 1 |
| Yes | 1.33 (1.13–1.57) | 1.02 (0.82–1.25) |
|
| ||
| No | 1 | 1 |
| Yes | 2.61 (2.15–3.18) | 1.24 (0.95–1.60) |
|
| ||
|
| ||
| No | 1 | 1 |
| Yes | 8.08 (6.67–9.79) | 3.99 (3.20–4.98) |
|
| ||
| No | 1 | 1 |
| Yes | 0.77 (0.65–0.91) | 0.56 (0.45–0.71) |
|
| ||
| No | 1 | 1 |
| Yes | 7.30 (5.93–8.99) | 2.97 (2.31–3.83) |
|
| ||
|
| ||
| No | 1 | 1 |
| Yes | 1.99 (1.67–2.38) | 1.04 (0.82–1.33) |
|
| ||
|
| ||
| No | 1 | 1 |
| Yes | 3.07 (2.45–3.85) | 1.54 (1.14–2.08) |
|
| ||
| No | 1 | 1 |
| Yes | 6.93 (5.77–8.32) | 3.91 (3.18–4.81) |
Note
*OR = Odds ratio; AOR = Adjusted odds ratio; CI = Confidence Interval; p-value significant at *<0.05 and
**<0.001.
Fig 3Receiver Operating Characteristic (ROC) analysis of the multivariable logistic regression model.